FDA Inspection 1068565 — Octapharma Plasma, Inc.
The FDA completed an inspection of Octapharma Plasma, Inc. on September 21, 2018 in South Bend, IN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 21, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- South Bend, IN (United States)